Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IBEX Technologies Inc V.IBT

Healthcare Biotechnology
IBEX Technologies Inc., through its wholly owned subsidiary, IBEX Pharmaceuticals Inc., manufactures and markets enzymes for biomedical use. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The Company has developed a... see more

Bullboard (TSXV:IBT)

View:
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 Next
Post by guarantor1on Nov 21, 2020 7:31am

I'm hoping Ibex brings in a 3rd Party Advisor

CIBC, BMO ETC ... DOES THIS SORT OF STUFF re Strategic Game Plans Why ? 1. Paul is late 70's 2. Ibex's record is not great when it comes to Deal Making- see Phenylase see Garvinci see North ...more  
755
Comment by midardon Nov 20, 2020 8:32pm

RE:Ibt says Revenue Increase may be due Heparin use for Covid

According to a recent poll 50% of Americans would refuse a Covid vaccine even if they were paid $100 After the Covid episode, all postponed surgeries will have to be done. Heparin will be in demand ...more  
45
Discussion
Post by guarantor1on Nov 20, 2020 3:36pm

Ibt says Revenue Increase may be due Heparin use for Covid

During COVID-19 WHAT A SURPRISE Revenues for the year ended July 31, 2020 totaled $5,209,809 compared to $4,308,320 in the prior year. The revenue increase traces mainly to customers ...more  
719
Discussion
Comment by guarantor1on Nov 19, 2020 9:05am

RE:Ibex employee Profit Sharing of $235K

$235k is substantial, but keep this in mind... "On November 1, 2018, Mr. Baehr’s base salary was raised to $340,508. However, as a cost-saving measure, Mr. Baehr elected ...more  
48
Discussion
Post by ARIMA11on Nov 19, 2020 9:03am

Numbers

www.wsj.com/livecoverage/covid-2020-11-19 The U.S. logged more than 170,000 newly reported Covid-19 cases for the second time, as the death toll crossed the quarter-million mark. Hospitalizations ...more  
699
Post by guarantor1on Nov 13, 2020 11:53am

Ibex employee Profit Sharing of $235K

Well and good ! And maybe it's time something is done for the shareholders ...perhaps a couple cents @ share payout to shareholders would be appropriate ? If not appropriate...I wonder why not, eh ...more  
762
Discussion
Post by ARIMA11on Nov 11, 2020 12:08pm

Interesting

https://nationalpost.com/news/world/pfizer-ceo-albert-bourla-sells-62-per-cent-of-shares-same-day-vaccine-announcement-made
185
Post by ARIMA11on Nov 11, 2020 11:13am

Hospitalizations

www.bloomberg.com/news/articles/2020-11-10/covid-roars-back-in-u-s-cities-after-months-as-a-rural-problem? Current hospitalizations with Covid-19 jumped to 59,275, close to the April 15 record of 59 ...more  
162
Post by ARIMA11on Nov 10, 2020 11:17am

Interesting

Nov 10 11:07:53 AM 0.275 5000   1 1 Nov 10 10:45:04 AM 0.28 25000   79 1  ...more  
66
Post by guarantor1on Nov 10, 2020 3:27am

Interesting Ibex shuffle in the Miller 16.5% Control Block

Neil Subin manages the 3 Lloyd Miller III Family Trusts, that hold 16.5% of Ibex. By far the largest holding . Paul Baehr,( our CEO,) holds just under 10% 1.5 M shares moved around last month ...more  
109
Post by midardon Nov 09, 2020 5:21pm

heparin is a pillar in the treatment of Covid-19

Treatment of COVID-19, renowned doctor reveals cure that politicians and experts rejected: It has positive effects and costs less!  ...more  
66
Post by guarantor1on Nov 09, 2020 3:20pm

Golfing and Paul Baehr's Ibex Persona....;-)

I belonged to a Montreal West Island golf club, early 2000's ... not the Royal but a close.wannabe. The Club was chock full of Pharma Execs. And I would be often paired up with these guys. It' ...more  
63
Comment by guarantor1on Nov 09, 2020 7:12am

RE:RE:When looking at Low Key Guidance for 2021...consider this !

" $.50 to $0.75 in the new year" isn't "crazy". imo, what is crazy is the current IBT shareprice, Given that i. Cash = 15 cents @ share (with zero debt) ii  P/S =1.4 ...more  
40
Discussion
Comment by guarantor1on Nov 09, 2020 6:49am

RE:Summary

Superb Summary ! Obviously IBT is on a few Radar Screens. ( for the first time in 15 years) Inflection Summary- IBEX Technologies Inc. (IBT.V) manufactures and market enzymes for biomedical use ...more  
75
Discussion
Post by ARIMA11on Nov 08, 2020 7:46pm

Summary

https://www.rally-co.ca/post/ibt-v-inflection
82
Discussion
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities